Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 20, 2018
Patent Application Number
14517497
Date Filed
October 17, 2014
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel acylated glucagon analog peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
